UGDH and glioblastoma: Additionally, 4-MU and UGDH knockdowns were shown to increase anti-tumor immune responses in GBM in vitro and in vivo by activating phagocytosis in tumor-residing macrophages, decreasing immune-suppressing regulatory T-cell activity, and increasing cytotoxic T-cell infiltration and activation [6].